


Premium Health operates a telehealth-focused obesity medicine practice serving patients throughout California from its Irvine headquarters. The clinic specializes in medically supervised weight loss programs utilizing GLP-1 receptor agonist peptides, specifically Semaglutide and Tirzepatide, prescribed and monitored by licensed healthcare providers experienced in metabolic medicine. Unlike traditional weight loss clinics requiring repeated in-person visits, Premium Health delivers comprehensive obesity treatment through HIPAA-compliant virtual consultations, allowing patients to receive medical evaluation, prescription management, and ongoing monitoring from their homes. The clinic's telehealth platform connects patients with nurse practitioners and physicians who conduct thorough metabolic assessments, review medical histories, and develop individualized treatment protocols based on each patient's weight loss goals, comorbidities, and response to therapy.
The clinic's weight loss programs center on two FDA-approved peptide medications repurposed for obesity management. Semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, works by regulating appetite signals in the brain while slowing gastric emptying to promote satiety and reduce caloric intake. Tirzepatide represents a dual-action approach, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors to enhance metabolic function and weight reduction. Premium Health sources these medications through an FDA-registered compounding pharmacy partner, ensuring quality control and proper handling of temperature-sensitive peptide formulations. Providers adjust dosing protocols based on patient tolerance and weight loss progression, typically starting with lower doses and titrating upward over several weeks to minimize gastrointestinal side effects while maximizing therapeutic benefit. Each prescription includes detailed administration instructions for subcutaneous self-injection, with nursing staff available via text or video to address injection technique questions or concerns about side effects.
The clinical team at Premium Health includes licensed nurse practitioners and physicians with specialized training in obesity medicine and metabolic disorders. Providers conduct initial consultations to assess candidacy for peptide therapy, reviewing factors such as body mass index, previous weight loss attempts, cardiovascular health, diabetes status, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. During ongoing treatment, patients receive regular check-ins to monitor weight loss progress, adjust medication dosing, and address any adverse effects such as nausea, constipation, or injection site reactions. The medical team emphasizes that peptide therapy works most effectively when combined with nutritional modifications and increased physical activity, though the clinic does not require patients to follow rigid meal plans or purchase proprietary food products. Providers offer evidence-based guidance on sustainable dietary changes and behavioral strategies to support long-term weight maintenance beyond the active treatment phase.
Patients beginning treatment with Premium Health complete an online intake form and medical questionnaire before their first telehealth appointment. The virtual consultation covers medical history, current medications, weight loss goals, and realistic expectations for peptide therapy outcomes. Following provider approval, prescriptions are transmitted electronically to the partnering compounding pharmacy, which ships medications directly to patients' homes with cold-chain packaging to maintain peptide stability. The clinic provides ongoing support through a patient portal and text-based communication system, allowing quick access to nursing staff for questions about dosing, side effects, or injection technique. Monthly follow-up consultations track weight loss metrics, assess tolerance to current dosing, and determine whether dose escalation or medication adjustment is appropriate. This structured monitoring approach helps identify patients who may need additional metabolic testing or referral for evaluation of underlying conditions affecting weight loss response.
Premium Health's telehealth model eliminates geographical barriers for California residents seeking medical weight loss treatment, particularly benefiting patients in Orange County communities including Irvine, Newport Beach, Costa Mesa, and surrounding areas who prefer virtual care over traditional clinic visits. The practice does not accept insurance for weight loss peptide programs, operating on a self-pay basis with transparent pricing for consultation fees and medication costs. Beyond obesity medicine, the clinic's infrastructure previously supported COVID-19 testing services, which accounts for review mentions of PCR tests, rapid testing, and outdoor testing tents, though the current clinical focus centers exclusively on metabolic health and weight management. The combination of experienced medical oversight, pharmaceutical-grade compounded peptides, and accessible telehealth delivery positions Premium Health as a resource for Irvine-area patients seeking structured, provider-supervised alternatives to over-the-counter weight loss supplements or unsupervised peptide use.
Topics Mentioned in Reviews
Semaglutide Weight Loss Program
One of the most effective medications for lasting weight loss, Semaglutide (the active ingredient used in Ozempic® and Wegovy®) is a non-habit forming weight loss treatment with minimal side effects.
Tirzepatide Weight Loss Program
Tirzepatide (active ingredient used in Mounjaro®) is the newest and most effective GLP-1 class medication for lasting weight loss.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


